1. Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

   • William R. Strohl
   • Zhiqiang Ku
   • Lila M. Strohl

   Leading Article Open access 27 April 2022 Pages: 231 - 323

   

2. Dengue Vaccines: An Update

   • Jesús M. Torres-Flores
   • Arturo Reyes-Sandoval
   • Ma Isabel Salazar

   Leading Article Open access 24 May 2022 Pages: 325 - 336

   

3. Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine

   • Fidel Dominique Festin Ambat
   • Enrico Bentivegna
   • Paolo Martelletti

   Commentary 16 May 2022 Pages: 337 - 339

4. Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale

   • Fred Cohen
   • Hsiangkuo Yuan
   • Stephen D. Silberstein

   Review Article 27 April 2022 Pages: 341 - 358

5. Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience

   • Pekka Kurki
   • Hye-Na Kang
   • Elena Wolff-Holz

   Review Article Open access 21 May 2022 Pages: 359 - 371

   

6. Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing

   • Alexander C. J. van Akkooi
   • Lisanne P. Zijlker
   • Michel W. J. M. Wouters

   Review Article Open access 09 April 2022 Pages: 373 - 380

7. Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study

   • Chin-Yao Shen
   • Philip Chun-Ming Au
   • Edward Chia-Cheng Lai

   Original Research Article 12 April 2022 Pages: 381 - 392

   

8. HLX11, a Proposed Pertuzumab Biosimilar: Pharmacokinetics, Immunogenicity, and Safety Profiles Compared to Three Reference Biologic Products (US-, EU-, and CN-Approved Pertuzumab) Administered to Healthy Male Subjects

   • Jingjing Yang
   • Lili Lin
   • Wei Hu

   Original Research Article Open access 20 May 2022 Pages: 393 - 409

   

9. Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry

   • Ji-Won Kim
   • Eunyoung A. Lee
   • Ju-Yang Jung

   Original Research Article 29 March 2022 Pages: 411 - 419

   

10. Embracing Change: An International Survey Study on the Beliefs and Attitudes of Pediatric Rheumatologists Towards Biosimilars

    • Fatma Gül Demirkan
    • Hafize Emine Sönmez
    • For the PeRA-Research Group

    Original Research Article 05 April 2022 Pages: 421 - 430